Literature DB >> 22151660

Continuous versus intermittent spinal cord stimulation: an analysis of factors influencing clinical efficacy.

Tilman Wolter1, Matthias Winkelmüller.   

Abstract

OBJECTIVES: Spinal cord stimulation (SCS) has, for decades, been shown to be successful in a variety of chronic neuropathic pain syndromes. However, there is a paucity of reports in the literature comparing different stimulation patterns. The impact of different stimulation patterns upon outcome remains to be determined, as well as how the latter is influenced by the duration of the post-SCS pain-free interval.
MATERIALS AND METHODS: Data from 61 patients (of 71 eligible patients) were collected by means of a telephone interview. These data included the pattern of stimulation (intermittent or continuous), the intensity of stimulation with regard to threshold, the mean, maximal, and minimal pain strength on a numerical rating scale with and without stimulation, the average duration and number of daily stimulation intervals, the average duration of the pain-relieving effect after switching off the impulse generator, the pain medication intake, the extent of paresthesia coverage, unpleasant side effects, and patient satisfaction.
RESULTS: The average improvement in pain score following SCS was 3.10 (50.61%). Twenty-four patients (39.3%) performed continuous stimulation, and 37 patients (60.7%) performed intermittent stimulation. Patients who performed continuous stimulation had significantly shorter pain-free intervals following the cessation of stimulation. These patients also showed a tendency toward higher pain scores with and without stimulation, which was not statistically significant. There were no significant differences in pain scores, duration of pain relief, and usage of the stimulation system between patients with different diagnoses and lead locations.
CONCLUSION: Our data showed an equal effectiveness of SCS in the intermittent and in the continuous stimulation mode. The duration of the post-SCS pain-free interval may be predictive for the choice of the most effective individual stimulation pattern and deserves further investigation.
© 2011 International Neuromodulation Society.

Entities:  

Mesh:

Year:  2011        PMID: 22151660     DOI: 10.1111/j.1525-1403.2011.00410.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  6 in total

1.  Dorsal column stimulator applications.

Authors:  Claudio Yampolsky; Santiago Hem; Damián Bendersky
Journal:  Surg Neurol Int       Date:  2012-10-31

Review 2.  Spinal cord stimulation for neuropathic pain: current perspectives.

Authors:  Tilman Wolter
Journal:  J Pain Res       Date:  2014-11-18       Impact factor: 3.133

3.  A Novel Approach in Spinal Cord Stimulation for Enhancing Gastric Motility: A Preliminary Study on Canines.

Authors:  Lei Tu; Payam Gharibani; Yi Yang; Bo Zhang; Feng Ji; Jieyun Yin; Jiande D Z Chen
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

4.  Spinal cord stimulation for chronic intractable trunk or limb pain: study protocol for a Chinese multicenter randomized withdrawal trial (CITRIP study).

Authors:  Yang Lu; Peng Mao; Guihuai Wang; Wei Tao; Donglin Xiong; Ke Ma; Rongchun Li; Dan Feng; Wanru Duan; Shun Li; Zhijian Fu; Zhiying Feng; Yi Jin; Li Wan; Yan Lu; Daying Zhang; Bifa Fan; James Jin Wang; Luming Li
Journal:  Trials       Date:  2020-10-07       Impact factor: 2.279

5.  Pulse Dosing of 10-kHz Paresthesia-Independent Spinal Cord Stimulation Provides the Same Efficacy with Substantial Reduction of Device Recharge Time.

Authors:  David Provenzano; Jordan Tate; Mayank Gupta; Cong Yu; Paul Verrills; Maged Guirguis; Nathan Harrison; Thomas Smith; Rose Azalde; Kerry Bradley
Journal:  Pain Med       Date:  2022-01-03       Impact factor: 3.750

6.  Novel Intermittent Dosing Burst Paradigm in Spinal Cord Stimulation.

Authors:  Timothy R Deer; Denis G Patterson; Javid Baksh; Jason E Pope; Pankaj Mehta; Adil Raza; Filippo Agnesi; Krishnan V Chakravarthy
Journal:  Neuromodulation       Date:  2020-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.